{"gene":"LTBP4","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1998,"finding":"LTBP-4 was identified as a novel member of the LTBP family, secreted from cultured human lung fibroblasts both in a free form and in a disulfide-bound complex with a TGF-beta LAP-like protein; both forms were deposited in the extracellular matrix, and matrix-associated LTBP-4 was susceptible to proteolytic release with plasmin. The 3rd 8-Cys repeat mediates association with TGF-beta.LAP.","method":"cDNA cloning, immunoblotting, ECM fractionation, plasmin treatment assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — original biochemical characterization with multiple orthogonal methods in a single foundational study","pmids":["9660815"],"is_preprint":false},{"year":1997,"finding":"LTBP-4 protein structure was determined to consist of 20 EG modules (17 with calcium-binding consensus), 4 TB (8-cysteine) modules, and several proline-rich regions, predicting it to be a microfibrillar protein that binds TGF-beta; it is encoded by a single ~5 kb mRNA highly expressed in heart.","method":"cDNA sequencing, Northern blot","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — sequence-based structural prediction validated by expression analysis, early characterization study","pmids":["9271198"],"is_preprint":false},{"year":2001,"finding":"A novel alternatively spliced form of LTBP-4 lacking the 3rd 8-Cys repeat (LTBP-4delta8-Cys3rd) was identified; this isoform does not bind TGF-beta, providing a mechanism to decrease TGF-beta deposition without altering structural ECM functions.","method":"RT-PCR, expression analysis in cell lines and tissues","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional splice variant identified by RT-PCR with TGF-beta binding attributed by domain deletion logic","pmids":["11683420"],"is_preprint":false},{"year":2002,"finding":"Disruption of LTBP-4 in mice results in severe pulmonary emphysema, cardiomyopathy, and colorectal cancer associated with defects in elastic fiber structure, reduced TGF-beta deposition in the extracellular space, reduced phospho-Smad2, overexpression of c-myc, and uncontrolled epithelial cell proliferation, establishing LTBP-4 as both a structural ECM component and a local regulator of TGF-beta tissue deposition and signaling.","method":"Gene trap knockout mouse model, histology, immunohistochemistry, phospho-Smad2 immunoblot, ECM analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined cellular and molecular phenotypes, highly cited foundational paper","pmids":["12208849"],"is_preprint":false},{"year":2004,"finding":"LTBP-4-deficient lung fibroblasts produce decreased active TGF-beta but increased secretion of latent TGF-beta, demonstrating LTBP-4 is required for TGF-beta activation (not secretion); loss of LTBP-4-mediated TGF-beta1 activation leads to enhanced BMP-4 signaling and decreased gremlin expression in the lung, a phenotype rescued by LTBP-4 transfection but not LTBP-1 transfection, and restored to wild-type by active TGF-beta1 treatment.","method":"Fibroblast cultures from LTBP-4-/- mice, TGF-beta bioassay, microarray, transfection rescue, cytokine treatment","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including KO cells, rescue experiments, and functional assays","pmids":["15466481"],"is_preprint":false},{"year":2008,"finding":"LTBP-4 possesses heparin-binding activity particularly in its N-terminal region; LTBP-4 binds directly to fibronectin (FN) through N-terminal sites, and FN is indispensable for ECM assembly of LTBP-4. In FN-/- fibroblasts, LTBP-mediated ECM targeting was disturbed and TGF-beta activity was increased. LTBP-4 C-terminal domain supports fibroblast adhesion, and heparin reduces both FN binding and cell adhesion.","method":"Heparin-affinity assay, pulldown/binding assay, cell adhesion assay, FN-/- fibroblasts, ECM fractionation, TGF-beta activity assay","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 1-2 — multiple direct binding assays and functional validation in FN-null cells with multiple readouts","pmids":["18585707"],"is_preprint":false},{"year":2009,"finding":"LTBP-4S null mice show defects in elastogenesis visible as early as E14.5 in alveolar walls, blood vessel media, and airway epithelium; the air-sac septation defect is associated with excessive TGF-beta2 signaling and is reversed by lowering TGF-beta2 levels, while normalization of TGF-beta signaling does not rescue elastogenesis, demonstrating two independent functions of LTBP-4: regulation of elastic fiber assembly and regulation of TGF-beta levels in lungs.","method":"Ltbp4S-/- mouse model, histology, TGF-beta2 neutralization, developmental stage analysis","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 — epistasis via TGF-beta2 neutralization dissecting two distinct LTBP-4 functions in the same model","pmids":["19016471"],"is_preprint":false},{"year":2009,"finding":"Recessive loss-of-function mutations in LTBP4 cause impaired synthesis and lack of deposition of LTBP4 into the ECM, resulting in increased TGF-beta activity in cultured fibroblasts and defective elastic fiber assembly in multiple human organ systems, demonstrating that LTBP4 couples TGF-beta signaling and ECM assembly.","method":"Human genetics (patient mutations), cell culture from patient fibroblasts, TGF-beta activity assay, ECM analysis, histology","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function with functional validation in patient fibroblasts across multiple methods","pmids":["19836010"],"is_preprint":false},{"year":2010,"finding":"LTBP-4L and LTBP-4S isoforms are regulated by two independent promoters with tissue-specific expression (liver expresses mainly LTBP-4L, lung and small intestine mainly LTBP-4S). During secretion, LTBP-4L complexes with TGF-beta1 while most LTBP-4S is secreted free. LTBP-4S is incorporated into the ECM while full-length LTBP-4L is not readily detectable in ECM.","method":"Northern blot, immunoblotting, ECM fractionation, promoter analysis, cell culture","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing isoform-specific differences in processing, complex formation, and ECM targeting","pmids":["20175115"],"is_preprint":false},{"year":2013,"finding":"IAAM haplotype fibroblasts exposed to TGF-beta display reduced phospho-SMAD signaling compared to VTTT haplotype fibroblasts, consistent with LTBP4's role as a regulator of TGF-beta; LTBP4 nonsynonymous coding variants (V194I, T787A, T820A, T1140M) influence age at loss of ambulation in DMD patients.","method":"Patient fibroblast TGF-beta stimulation assay, phospho-SMAD immunoblot, clinical cohort genotyping","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional fibroblast assay supporting genetic association, single method for mechanism","pmids":["23440719"],"is_preprint":false},{"year":2015,"finding":"Inactivation of both LTBP-4 isoforms (Ltbp4-/-) in mice revealed that LTBP-4L is specifically required for incorporation of fibulin-4 into the ECM. Fibulin-4 was identified as a novel interaction partner of both LTBP-4 isoforms by co-immunoprecipitation. In Ltbp4S-/- mice (expressing only LTBP-4L), fibulin-4 ECM incorporation was normal, but was defective in Ltbp4-/- mice.","method":"Ltbp4-/- mouse model, co-immunoprecipitation, ECM fractionation, comparative analysis of isoform-specific knockout mice","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — Co-IP identification of interaction partner plus functional validation in isoform-specific knockout models","pmids":["25713297"],"is_preprint":false},{"year":2016,"finding":"Genetic epistasis in Ltbp4S-/-;Fibulin-4R/R compound mice showed severely impaired elastogenesis, defective alveolar septation, fragmented elastic lamellae, and aortic aneurysm formation not seen in single mutants alone, establishing a functional interaction between Ltbp-4L and fibulin-4 as a crucial requirement for survival and elastogenesis in vivo.","method":"Compound mutant mouse genetics, histology, survival analysis","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — clean genetic epistasis with multiple defined phenotypic readouts confirming biochemical interaction","pmids":["27585882"],"is_preprint":false},{"year":2016,"finding":"LTBP4 induces Pdgfrβ signaling by inhibiting the antioxidant Nrf2/Keap1 pathway in a TGF-beta-dependent manner; Ltbp4S-/- mice have defective Pdgfrβ signaling contributing to pulmonary emphysema.","method":"Ltbp4S-/- mouse model, gene expression analysis, pathway inhibition/activation experiments","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — pathway placement by KO with molecular readouts but limited direct mechanistic validation","pmids":["27645114"],"is_preprint":false},{"year":2017,"finding":"Three interacting mechanisms contribute to alveolar septation defects in Ltbp4-/- lungs: absence of intact elastic fiber network, reduced angiogenesis, and upregulation of TGF-beta activity resulting in profibrotic processes.","method":"Ltbp4-/- mouse lung analysis, histology, angiogenesis assays, TGF-beta signaling readouts","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — KO model with multiple defined mechanistic readouts in a single study","pmids":["28684544"],"is_preprint":false},{"year":2018,"finding":"Pro-inflammatory Ly6Cpos macrophages in DMD muscle exhibit high LTBP4 expression, producing elevated latent-TGF-beta1; AMPK activation decreases ltbp4 expression in these macrophages, reducing latent-TGF-beta1 production and fibrosis. Fibro-adipogenic progenitors provide TGF-beta-activating enzymes that act on LTBP4-sequestered TGF-beta1 to produce collagen from fibroblasts, establishing an AMPK-LTBP4 axis controlling TGF-beta1 production and fibrosis in DMD.","method":"Mouse and human DMD muscle analysis, macrophage isolation, AMPK activation (AICAR treatment), ltbp4 knockdown, fibroblast collagen assays, in vivo pharmacological inhibition","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vitro and in vivo experiments with defined molecular mechanism and phenotypic readouts","pmids":["30463013"],"is_preprint":false},{"year":2018,"finding":"Long-range regulatory variants at the LTBP4 locus (tagged by rs710160 on chr19) are associated with prolonged ambulation in DMD, with chromatin interaction data indicating these SNPs regulate LTBP4 expression; THBS1 (thrombospondin-1) was identified as an activator of TGF-beta signaling by direct binding to LTBP4.","method":"GWAS, gene expression databases, chromatin interaction analysis","journal":"Annals of neurology","confidence":"Low","confidence_rationale":"Tier 4 — GWAS/computational analysis; THBS1 direct binding to LTBP4 cited without direct experimental evidence in this paper","pmids":["30014611"],"is_preprint":false},{"year":2019,"finding":"Fibulin-4 induces a conformational switch in LTBP-4L from a compact to an elongated structure; this conformational change is induced only by fibulin-4 multimers (not monomers) through increased avidity, and results in enhanced LTBP-4L binding to fibronectin and fibrillin-1, increased LTBP-4L assembly, and promotion of tropoelastin deposition onto elongated LTBP-4L. Fibulin-4 acts as a molecular extracellular chaperone for LTBP-4L.","method":"Biophysical conformational assays, binding assays (fibronectin, fibrillin-1, tropoelastin), recombinant protein reconstitution, fibulin-4 monomer vs multimer comparison","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with multiple binding assays, conformational analysis, mechanistic mutagenesis-equivalent (monomer vs multimer), single rigorous paper","pmids":["31548410"],"is_preprint":false},{"year":2021,"finding":"LTBP4 deficiency (Ltbp4S-/- mice) leads to aggravated tubular interstitial fibrosis after unilateral ureteral obstruction; LTBP4 overexpression in proximal tubule cells stimulates angiogenesis via VEGFA upregulation and VEGFR activation in endothelial cells. LTBP4-deficient mice show aberrant angiogenesis, abnormal mitochondrial morphology, and enhanced oxidative stress.","method":"Ltbp4S-/- mouse UUO model, LTBP4 overexpression in HK-2 cells, transcriptomic analysis, tube formation assay, mitochondrial morphology analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple readouts in KO mouse and overexpression model, novel non-TGF-beta functions identified","pmids":["34645813"],"is_preprint":false},{"year":2021,"finding":"Aberrant interaction between mutated ADAMTSL2 and LTBP4 upregulates TGF-beta signaling in human fibroblasts; variant pairs in ADAMTSL2-LTBP4 affect the protein-protein interaction between these two molecules.","method":"Exome sequencing, Co-IP/interaction assay in human fibroblasts, TGF-beta signaling readout","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 — single interaction/functional assay in patient-derived context demonstrating ADAMTSL2 as LTBP4 binding partner","pmids":["34958866"],"is_preprint":false},{"year":2022,"finding":"YAP overexpression in vascular smooth muscle cells promotes LTBP4 expression; silencing LTBP4 abolishes the protective role of YAP against abdominal aortic aneurysm formation, placing LTBP4 downstream of YAP in elastic fiber assembly in VSMCs.","method":"VSMC-specific YAP overexpression mouse model, LTBP4 silencing in vivo, AAA experimental model, histology","journal":"Journal of cardiovascular translational research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in vivo with defined phenotypic readout placing LTBP4 in YAP pathway","pmids":["35708897"],"is_preprint":false},{"year":2022,"finding":"LTBP4 knockdown in melanoma cells increases the percentage of active TGF-beta1 secreted; active TGF-beta1 inhibits YAP1 phosphorylation and induces YAP1 nuclear translocation, reducing Hippo signaling targets CTGF, Cyr61, and Birc5. LTBP4 overexpression activates the Hippo pathway via increased YAP1 phosphorylation and nuclear-cytoplasmic translocation, suppressing proliferation and metastasis.","method":"LTBP4 KD/OE in melanoma cells, ELISA for active TGF-beta1, immunofluorescence, Western blot, luciferase reporter, nude mouse tumor formation","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods linking LTBP4 to TGF-beta1 activation and Hippo-YAP1 pathway with functional readouts","pmids":["35252214"],"is_preprint":false},{"year":2023,"finding":"LTBP4 deficiency in mice and HK-2 cells increases mitochondrial fragmentation (DRP1-dependent), decreases ATP production, reduces mitochondrial respiration and glycolysis, increases oxidative stress, and reduces angiogenesis after ischemia-reperfusion injury. Inhibition of DRP1-dependent mitochondrial fission ameliorated inflammation, oxidative stress, and fibrosis in LTBP4-deficient mice.","method":"Ltbp4 KD mice, IRI model, LTBP4 KD HK-2 cells, mitochondrial function assays (bioenergetics), DRP1 inhibitor treatment, angiogenesis assays with conditioned media","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic studies linking LTBP4 to DRP1-dependent mitochondrial dynamics with pharmacological rescue","pmids":["37232163"],"is_preprint":false},{"year":2025,"finding":"N-linked glycans of LTBP-4L (but not fibulin-4) are critical for fibulin-4-mediated conformational extension of LTBP-4L; fibulin-5 strongly interacts with and induces conformational extension of LTBP-4S, requiring N-linked glycans of fibulin-5, leading to enhanced fibronectin binding, increased LTBP-4S deposition, and doubled elastic fiber formation. Two distinct molecular axes were defined: LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5, with synergistic effects on elastogenesis.","method":"Glycoproteomic analysis, enzymatic glycan removal, biophysical binding assays, recombinant protein reconstitution, elastic fiber formation assay","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with glycoproteomic analysis, multiple orthogonal biophysical and functional assays","pmids":["40608550"],"is_preprint":false}],"current_model":"LTBP4 is an extracellular matrix glycoprotein that sequesters latent TGF-beta in the ECM via its 3rd 8-cysteine domain and is essential for TGF-beta activation (not secretion); it directly binds fibronectin via its N-terminal region for ECM assembly, interacts with fibulin-4 (which acts as a molecular chaperone inducing a compact-to-extended conformational switch in LTBP-4L) and fibulin-5 (which similarly extends LTBP-4S) to facilitate tropoelastin deposition and elastic fiber formation, with two isoforms (LTBP-4L and LTBP-4S) regulated by independent promoters showing distinct TGF-beta binding, secretion, and ECM targeting properties; loss of LTBP-4 function results in impaired TGF-beta activation leading to enhanced BMP-4 signaling, defective elastogenesis, and—through an AMPK-regulated axis in macrophages—promotes fibrosis via excess latent TGF-beta1 production."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing LTBP4 as a new member of the LTBP/fibrillin superfamily resolved its modular domain architecture (20 EG modules, 4 TB/8-Cys modules) and predicted it to be a TGF-beta-binding microfibrillar protein.","evidence":"cDNA sequencing and Northern blot showing high cardiac expression","pmids":["9271198"],"confidence":"Medium","gaps":["No direct demonstration of TGF-beta binding at this stage","Protein-level validation not performed"]},{"year":1998,"claim":"Demonstrating that LTBP-4 forms disulfide-linked complexes with TGF-beta LAP via its 3rd 8-Cys repeat and is deposited in the ECM established it as a bona fide TGF-beta-sequestering matrix protein.","evidence":"cDNA cloning, immunoblotting, ECM fractionation, and plasmin release assay in human lung fibroblasts","pmids":["9660815"],"confidence":"High","gaps":["Whether LTBP-4 is required for TGF-beta activation versus secretion was unknown","In vivo relevance not yet tested"]},{"year":2001,"claim":"Identification of a splice variant lacking the 3rd 8-Cys repeat revealed a mechanism for uncoupling LTBP4's structural ECM role from TGF-beta sequestration.","evidence":"RT-PCR and expression analysis across cell lines and tissues","pmids":["11683420"],"confidence":"Medium","gaps":["Functional significance of this variant in vivo was not tested","Relative abundance across tissues not quantified at protein level"]},{"year":2002,"claim":"Knockout of LTBP-4 in mice produced emphysema, cardiomyopathy, and colorectal cancer with reduced ECM TGF-beta deposition and phospho-Smad2, establishing LTBP4 as essential for both elastic fiber integrity and local TGF-beta signaling in vivo.","evidence":"Gene trap knockout mouse with histology, immunohistochemistry, and phospho-Smad2 immunoblot","pmids":["12208849"],"confidence":"High","gaps":["Mechanism of TGF-beta activation versus secretion not dissected","Contribution of individual isoforms unclear"]},{"year":2004,"claim":"Using LTBP-4-null fibroblasts resolved that LTBP4 is required for TGF-beta activation (not secretion), and showed that loss of this activation leads to compensatory BMP-4 upregulation — a phenotype rescued by LTBP-4 but not LTBP-1 transfection.","evidence":"TGF-beta bioassay, microarray, and rescue experiments in Ltbp4−/− fibroblasts","pmids":["15466481"],"confidence":"High","gaps":["Molecular mechanism by which LTBP4 promotes TGF-beta activation not defined","Whether LTBP-4L or LTBP-4S mediates this effect was not resolved"]},{"year":2008,"claim":"Mapping LTBP-4's N-terminal fibronectin-binding and heparin-binding sites, and showing that fibronectin is indispensable for LTBP-4 ECM assembly, established the upstream requirement for fibronectin in LTBP4-mediated TGF-beta regulation.","evidence":"Binding assays, cell adhesion assays, and ECM fractionation in FN−/− fibroblasts","pmids":["18585707"],"confidence":"High","gaps":["Structural basis of the FN–LTBP4 interaction not resolved","Whether fibronectin binding differs between LTBP-4L and LTBP-4S not tested"]},{"year":2009,"claim":"Isoform-specific (Ltbp4S−/−) knockout and TGF-beta2 neutralization dissected two independent functions of LTBP4 — elastic fiber assembly and TGF-beta regulation — since normalizing TGF-beta signaling rescued septation but not elastogenesis.","evidence":"Ltbp4S−/− mice with TGF-beta2 neutralization and developmental histology","pmids":["19016471"],"confidence":"High","gaps":["Molecular mechanism of the elastogenesis-specific function not identified","Whether LTBP-4L compensates partially in LTBP-4S-null lung unclear"]},{"year":2009,"claim":"Human recessive LTBP4 mutations causing impaired LTBP4 ECM deposition, increased TGF-beta activity, and defective elastic fibers in multiple organs established LTBP4 as a Mendelian connective tissue disease gene.","evidence":"Patient genetics with functional validation in patient fibroblasts and tissue histology","pmids":["19836010"],"confidence":"High","gaps":["Genotype–phenotype correlation across different mutations not fully mapped","Whether residual LTBP-4 function modifies severity unknown"]},{"year":2010,"claim":"Characterizing two independent promoters driving LTBP-4L and LTBP-4S with distinct tissue expression, TGF-beta1 complex formation, and ECM incorporation properties explained why different tissues are differentially affected by LTBP4 loss.","evidence":"Northern blot, immunoblotting, ECM fractionation, and promoter analysis","pmids":["20175115"],"confidence":"High","gaps":["Transcriptional regulators of each promoter not identified","Post-translational regulation of isoform-specific functions not explored"]},{"year":2015,"claim":"Identification of fibulin-4 as a direct LTBP-4 binding partner, with LTBP-4L specifically required for fibulin-4 ECM incorporation, linked the two proteins in a shared elastogenic pathway.","evidence":"Co-immunoprecipitation and comparative ECM analysis in Ltbp4S−/− versus Ltbp4−/− mice","pmids":["25713297"],"confidence":"High","gaps":["Binding domain on LTBP-4 not mapped","Whether fibulin-4 reciprocally affects LTBP-4 conformation was unknown"]},{"year":2016,"claim":"Compound Ltbp4S−/−;Fibulin-4R/R mutant mice displayed synergistic lethality and elastogenic defects not seen in either single mutant, confirming functional interdependence of LTBP-4 and fibulin-4 in vivo.","evidence":"Compound mutant mouse genetics with survival analysis and histology","pmids":["27585882"],"confidence":"High","gaps":["Whether therapeutic supplementation of either protein can rescue the compound phenotype not tested"]},{"year":2018,"claim":"Demonstrating that pro-inflammatory macrophages produce LTBP4-bound latent TGF-beta1 under AMPK regulation, which is then activated by fibro-adipogenic progenitor-derived enzymes to drive collagen deposition, placed LTBP4 at the center of an inflammatory–fibrotic axis in DMD muscle.","evidence":"Macrophage isolation from DMD muscle, AMPK activation with AICAR, ltbp4 knockdown, fibroblast collagen assays, and in vivo pharmacology","pmids":["30463013"],"confidence":"High","gaps":["Identity of the FAP-derived TGF-beta-activating enzymes acting on LTBP4-sequestered complexes not determined","Whether this axis operates in non-muscular fibrotic diseases unknown"]},{"year":2019,"claim":"Reconstitution experiments revealed that fibulin-4 multimers (not monomers) act as an extracellular chaperone switching LTBP-4L from a compact to an elongated conformation, thereby enhancing its binding to fibronectin and fibrillin-1 and promoting tropoelastin deposition.","evidence":"Recombinant protein reconstitution with biophysical conformational assays, binding assays, and monomer versus multimer comparison","pmids":["31548410"],"confidence":"High","gaps":["Structural details of the compact versus extended states not resolved at atomic level","Whether the conformational switch is reversible in vivo not known"]},{"year":2022,"claim":"Placing LTBP4 downstream of YAP in vascular smooth muscle cells, and showing that LTBP4 silencing abolishes YAP's protective effect against aortic aneurysm, identified a transcriptional regulatory input into LTBP4 expression relevant to vascular disease.","evidence":"VSMC-specific YAP overexpression mouse model with LTBP4 silencing and AAA phenotyping","pmids":["35708897"],"confidence":"Medium","gaps":["Direct transcriptional regulation of the LTBP4 promoter by YAP not demonstrated","Reciprocal LTBP4-to-YAP signaling via TGF-beta creates potential confounding"]},{"year":2023,"claim":"Linking LTBP4 deficiency to DRP1-dependent mitochondrial fragmentation, reduced bioenergetics, and increased oxidative stress — phenotypes rescued by DRP1 inhibition — revealed an unexpected intracellular consequence of LTBP4 loss beyond canonical ECM functions.","evidence":"LTBP4 knockdown in HK-2 cells and mice with IRI, mitochondrial bioenergetic profiling, and DRP1 inhibitor rescue","pmids":["37232163"],"confidence":"Medium","gaps":["Whether the mitochondrial phenotype is a direct effect or secondary to altered TGF-beta signaling not resolved","Mechanism linking an ECM protein to DRP1 regulation not defined"]},{"year":2025,"claim":"Demonstrating that N-linked glycans on LTBP-4L are required for fibulin-4-induced extension, while fibulin-5 glycans drive LTBP-4S extension, defined two parallel glycan-dependent molecular axes (LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5) that synergistically promote elastogenesis.","evidence":"Glycoproteomic analysis, enzymatic glycan removal, biophysical binding assays, recombinant reconstitution, and elastic fiber formation assay","pmids":["40608550"],"confidence":"High","gaps":["Specific glycan sites critical for each interaction not mapped","In vivo validation of the dual-axis model not yet performed"]},{"year":null,"claim":"The molecular mechanism by which LTBP4 promotes TGF-beta activation (as opposed to mere sequestration) remains undefined, as does the structural basis for the compact-to-extended conformational transition at atomic resolution.","evidence":"","pmids":[],"confidence":"High","gaps":["No reconstituted TGF-beta activation assay using purified LTBP4","Atomic-resolution structure of LTBP-4 in compact versus extended states unavailable","How the two isoform-specific elastogenic axes are coordinated in vivo during development is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,6,14]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[3,6,11,16,22]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,3,5,7,8,10,16,22]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,5,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,4,6,7,9,14,20]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[3,5,6,10,11,16,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,11,22]}],"complexes":["Latent TGF-beta complex (large latent complex)"],"partners":["TGFB1","FN1","FBLN4","FBLN5","FBN1","ELN","ADAMTSL2"],"other_free_text":[]},"mechanistic_narrative":"LTBP4 is an extracellular matrix glycoprotein that serves dual functions as a structural scaffold for elastic fiber assembly and as a critical regulator of TGF-beta bioavailability. It sequesters latent TGF-beta in the ECM via its 3rd 8-cysteine repeat domain and is required for TGF-beta activation rather than secretion; loss of LTBP4 paradoxically increases latent TGF-beta secretion while reducing active TGF-beta, leading to compensatory BMP-4 upregulation in the lung [PMID:15466481, PMID:9660815]. Two isoforms (LTBP-4L and LTBP-4S), driven by independent promoters with distinct tissue expression and TGF-beta binding properties, undergo conformational extension upon interaction with fibulin-4 (LTBP-4L) or fibulin-5 (LTBP-4S), an N-glycan-dependent process that enhances fibronectin binding and tropoelastin deposition for elastic fiber formation [PMID:31548410, PMID:40608550, PMID:20175115]. Recessive loss-of-function mutations in LTBP4 cause a human connective tissue disorder with defective elastic fiber assembly and increased TGF-beta activity across multiple organ systems [PMID:19836010]."},"prefetch_data":{"uniprot":{"accession":"Q8N2S1","full_name":"Latent-transforming growth factor beta-binding protein 4","aliases":[],"length_aa":1624,"mass_kda":173.4,"function":"Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/Q8N2S1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LTBP4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":74,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LTBP4","total_profiled":1310},"omim":[{"mim_id":"613177","title":"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C","url":"https://www.omim.org/entry/613177"},{"mim_id":"604710","title":"LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4","url":"https://www.omim.org/entry/604710"},{"mim_id":"604580","title":"FIBULIN 5; FBLN5","url":"https://www.omim.org/entry/604580"},{"mim_id":"602194","title":"HTRA SERINE PEPTIDASE 1; HTRA1","url":"https://www.omim.org/entry/602194"},{"mim_id":"600142","title":"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY 2; CARASIL2","url":"https://www.omim.org/entry/600142"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"blood vessel","ntpm":548.8}],"url":"https://www.proteinatlas.org/search/LTBP4"},"hgnc":{"alias_symbol":["LTBP-4","LTBP-4L","FLJ46318","FLJ90018"],"prev_symbol":[]},"alphafold":{"accession":"Q8N2S1","domains":[{"cath_id":"-","chopping":"286-325","consensus_level":"medium","plddt":78.4613,"start":286,"end":325},{"cath_id":"2.10.25.10","chopping":"355-402","consensus_level":"medium","plddt":73.794,"start":355,"end":402},{"cath_id":"3.90.290.10","chopping":"410-474","consensus_level":"medium","plddt":77.6711,"start":410,"end":474},{"cath_id":"-","chopping":"768-879","consensus_level":"medium","plddt":74.8611,"start":768,"end":879},{"cath_id":"2.10.25.10","chopping":"882-922","consensus_level":"medium","plddt":74.4085,"start":882,"end":922},{"cath_id":"-","chopping":"970-1006","consensus_level":"medium","plddt":71.6995,"start":970,"end":1006},{"cath_id":"-","chopping":"1093-1128","consensus_level":"medium","plddt":77.9158,"start":1093,"end":1128},{"cath_id":"3.90.290.10","chopping":"1311-1403","consensus_level":"medium","plddt":74.0032,"start":1311,"end":1403},{"cath_id":"2.10.25.10","chopping":"1531-1576","consensus_level":"medium","plddt":73.9213,"start":1531,"end":1576},{"cath_id":"2.10.25.10","chopping":"1586-1624","consensus_level":"medium","plddt":78.9669,"start":1586,"end":1624}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N2S1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N2S1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N2S1-F1-predicted_aligned_error_v6.png","plddt_mean":62.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LTBP4","jax_strain_url":"https://www.jax.org/strain/search?query=LTBP4"},"sequence":{"accession":"Q8N2S1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N2S1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N2S1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N2S1"}},"corpus_meta":[{"pmid":"12208849","id":"PMC_12208849","title":"Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12208849","citation_count":205,"is_preprint":false},{"pmid":"23440719","id":"PMC_23440719","title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.","date":"2013","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23440719","citation_count":202,"is_preprint":false},{"pmid":"30463013","id":"PMC_30463013","title":"AMPK Activation Regulates LTBP4-Dependent TGF-β1 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30463013","citation_count":178,"is_preprint":false},{"pmid":"19836010","id":"PMC_19836010","title":"Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19836010","citation_count":122,"is_preprint":false},{"pmid":"9660815","id":"PMC_9660815","title":"Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9660815","citation_count":113,"is_preprint":false},{"pmid":"25476005","id":"PMC_25476005","title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.","date":"2014","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25476005","citation_count":78,"is_preprint":false},{"pmid":"9271198","id":"PMC_9271198","title":"Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9271198","citation_count":65,"is_preprint":false},{"pmid":"15466481","id":"PMC_15466481","title":"Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15466481","citation_count":63,"is_preprint":false},{"pmid":"18585707","id":"PMC_18585707","title":"Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18585707","citation_count":55,"is_preprint":false},{"pmid":"19016471","id":"PMC_19016471","title":"Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta activity.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19016471","citation_count":54,"is_preprint":false},{"pmid":"30014611","id":"PMC_30014611","title":"Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30014611","citation_count":42,"is_preprint":false},{"pmid":"25713297","id":"PMC_25713297","title":"Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms.","date":"2015","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25713297","citation_count":39,"is_preprint":false},{"pmid":"34294164","id":"PMC_34294164","title":"The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.","date":"2021","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/34294164","citation_count":38,"is_preprint":false},{"pmid":"20375427","id":"PMC_20375427","title":"The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.","date":"2010","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20375427","citation_count":38,"is_preprint":false},{"pmid":"34071145","id":"PMC_34071145","title":"LTBP4 in Health and Disease.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34071145","citation_count":34,"is_preprint":false},{"pmid":"29481844","id":"PMC_29481844","title":"Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.","date":"2018","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29481844","citation_count":32,"is_preprint":false},{"pmid":"20175115","id":"PMC_20175115","title":"Independent regulation of short and long forms of latent TGF-beta binding protein (LTBP)-4 in cultured fibroblasts and human tissues.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20175115","citation_count":32,"is_preprint":false},{"pmid":"31548410","id":"PMC_31548410","title":"Fibulin-4 exerts a dual role in LTBP-4L-mediated matrix assembly and function.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31548410","citation_count":28,"is_preprint":false},{"pmid":"11683420","id":"PMC_11683420","title":"Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11683420","citation_count":24,"is_preprint":false},{"pmid":"37232163","id":"PMC_37232163","title":"LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37232163","citation_count":22,"is_preprint":false},{"pmid":"34645813","id":"PMC_34645813","title":"LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34645813","citation_count":22,"is_preprint":false},{"pmid":"27585882","id":"PMC_27585882","title":"Function of Ltbp-4L and fibulin-4 in survival and elastogenesis in mice.","date":"2016","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/27585882","citation_count":22,"is_preprint":false},{"pmid":"21468687","id":"PMC_21468687","title":"Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.","date":"2011","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/21468687","citation_count":21,"is_preprint":false},{"pmid":"28684544","id":"PMC_28684544","title":"Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs.","date":"2017","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28684544","citation_count":18,"is_preprint":false},{"pmid":"17550376","id":"PMC_17550376","title":"Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.","date":"2007","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/17550376","citation_count":18,"is_preprint":false},{"pmid":"19836277","id":"PMC_19836277","title":"Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.","date":"2009","source":"Veterinary journal (London, England : 1997)","url":"https://pubmed.ncbi.nlm.nih.gov/19836277","citation_count":16,"is_preprint":false},{"pmid":"35252214","id":"PMC_35252214","title":"Disruption of LTBP4 Inhibition-Induced TGFβ1 Activation Promoted Cell Proliferation and Metastasis in Skin Melanoma by Inhibiting the Activation of the Hippo-YAP1 Signaling Pathway.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35252214","citation_count":14,"is_preprint":false},{"pmid":"31115174","id":"PMC_31115174","title":"Clinical and molecular characterization of an 18-month-old infant with autosomal recessive cutis laxa type 1C due to a novel LTBP4 pathogenic variant, and literature review.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31115174","citation_count":11,"is_preprint":false},{"pmid":"27645114","id":"PMC_27645114","title":"Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function.","date":"2016","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27645114","citation_count":11,"is_preprint":false},{"pmid":"29766838","id":"PMC_29766838","title":"DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.","date":"2018","source":"Cardiology in the young","url":"https://pubmed.ncbi.nlm.nih.gov/29766838","citation_count":9,"is_preprint":false},{"pmid":"34958866","id":"PMC_34958866","title":"Aberrant interaction between mutated ADAMTSL2 and LTBP4 is associated with adolescent idiopathic scoliosis.","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34958866","citation_count":8,"is_preprint":false},{"pmid":"32764991","id":"PMC_32764991","title":"Disruption of LTBP4 Induced Activated TGFβ1, Immunosuppression Signal and Promoted Pulmonary Metastasis in Hepatocellular Carcinoma.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32764991","citation_count":8,"is_preprint":false},{"pmid":"36011296","id":"PMC_36011296","title":"LTBP4, SPP1, and CD40 Variants: Genetic Modifiers of Duchenne Muscular Dystrophy Analyzed in Serbian Patients.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36011296","citation_count":8,"is_preprint":false},{"pmid":"33302946","id":"PMC_33302946","title":"Two novel compound heterozygous variants of LTBP4 in a Chinese infant with cutis laxa type IC and a review of the related literature.","date":"2020","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33302946","citation_count":4,"is_preprint":false},{"pmid":"35708897","id":"PMC_35708897","title":"Specific Overexpression of YAP in Vascular Smooth Muscle Attenuated Abdominal Aortic Aneurysm Formation by Activating Elastic Fiber Assembly via LTBP4.","date":"2022","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35708897","citation_count":4,"is_preprint":false},{"pmid":"35972031","id":"PMC_35972031","title":"First report of a short in-frame biallelic deletion removing part of the EGF-like domain calcium-binding motif in LTBP4 and causing autosomal recessive cutis laxa type 1C.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35972031","citation_count":3,"is_preprint":false},{"pmid":"35445908","id":"PMC_35445908","title":"Autosomal recessive cutis laxa type 1C with a homozygous LTBP4 splicing variant: a case report and update of literature.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35445908","citation_count":3,"is_preprint":false},{"pmid":"32341818","id":"PMC_32341818","title":"Identification of a Novel 19-bp Deletion Mutation in LTBP4 Using Exome Sequencing in Two Siblings with Autosomal Recessive Cutis Laxa Type 1C.","date":"2019","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32341818","citation_count":3,"is_preprint":false},{"pmid":"38363615","id":"PMC_38363615","title":"The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.","date":"2024","source":"Journal of neuromuscular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38363615","citation_count":2,"is_preprint":false},{"pmid":"39193795","id":"PMC_39193795","title":"Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/39193795","citation_count":1,"is_preprint":false},{"pmid":"41194282","id":"PMC_41194282","title":"Constitutional epimutations in LTBP4, a component of the TGF-β signaling, and in BRCA1, as potential drivers of early-onset colorectal cancer.","date":"2025","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/41194282","citation_count":1,"is_preprint":false},{"pmid":"38547642","id":"PMC_38547642","title":"Novel indel variation of LTBP4 gene associates with risk of sudden cardiac death in Chinese populations with coronary artery disease.","date":"2024","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/38547642","citation_count":1,"is_preprint":false},{"pmid":"40608550","id":"PMC_40608550","title":"Impact of N-linked glycans on the dual short fibulin/LTBP-4 axes regulating elastogenesis.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/40608550","citation_count":0,"is_preprint":false},{"pmid":"41388516","id":"PMC_41388516","title":"Fibulin-5 promotes fibroblast activation through LTBP-4 to improve the pathogenesis of hemorrhoids.","date":"2025","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/41388516","citation_count":0,"is_preprint":false},{"pmid":"41076474","id":"PMC_41076474","title":"Deleterious variants in LTBP4 are associated with severe pediatric sepsis.","date":"2025","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/41076474","citation_count":0,"is_preprint":false},{"pmid":"36524797","id":"PMC_36524797","title":"Association of polymorphisms rs2303729, rs10880, and rs1131620 of LTBP4 with sarcopenia in elderly patients with type 2 diabetes mellitus.","date":"2022","source":"Annals of human biology","url":"https://pubmed.ncbi.nlm.nih.gov/36524797","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.18.657655","title":"Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeutics","date":"2025-06-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.657655","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.21.666043","title":"The Tricuspid Valve is Transcriptionally Active During Prolonged Pressure Overload, Right-Sided Heart Failure, and Valve Regurgitation","date":"2025-07-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.21.666043","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.20.655139","title":"Validation of Duchenne muscular dystrophy candidate modifiers using a CRISPR-Cas9-based approach in zebrafish","date":"2025-05-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.20.655139","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.20.24314065","title":"Plasma proteomics reveals the potential causal impact of extracellular matrix proteins on abdominal aortic aneurysm","date":"2024-09-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.20.24314065","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27874,"output_tokens":5982,"usd":0.086676},"stage2":{"model":"claude-opus-4-6","input_tokens":9540,"output_tokens":3867,"usd":0.216562},"total_usd":0.303238,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"LTBP-4 was identified as a novel member of the LTBP family, secreted from cultured human lung fibroblasts both in a free form and in a disulfide-bound complex with a TGF-beta LAP-like protein; both forms were deposited in the extracellular matrix, and matrix-associated LTBP-4 was susceptible to proteolytic release with plasmin. The 3rd 8-Cys repeat mediates association with TGF-beta.LAP.\",\n      \"method\": \"cDNA cloning, immunoblotting, ECM fractionation, plasmin treatment assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original biochemical characterization with multiple orthogonal methods in a single foundational study\",\n      \"pmids\": [\"9660815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LTBP-4 protein structure was determined to consist of 20 EG modules (17 with calcium-binding consensus), 4 TB (8-cysteine) modules, and several proline-rich regions, predicting it to be a microfibrillar protein that binds TGF-beta; it is encoded by a single ~5 kb mRNA highly expressed in heart.\",\n      \"method\": \"cDNA sequencing, Northern blot\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — sequence-based structural prediction validated by expression analysis, early characterization study\",\n      \"pmids\": [\"9271198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A novel alternatively spliced form of LTBP-4 lacking the 3rd 8-Cys repeat (LTBP-4delta8-Cys3rd) was identified; this isoform does not bind TGF-beta, providing a mechanism to decrease TGF-beta deposition without altering structural ECM functions.\",\n      \"method\": \"RT-PCR, expression analysis in cell lines and tissues\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional splice variant identified by RT-PCR with TGF-beta binding attributed by domain deletion logic\",\n      \"pmids\": [\"11683420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Disruption of LTBP-4 in mice results in severe pulmonary emphysema, cardiomyopathy, and colorectal cancer associated with defects in elastic fiber structure, reduced TGF-beta deposition in the extracellular space, reduced phospho-Smad2, overexpression of c-myc, and uncontrolled epithelial cell proliferation, establishing LTBP-4 as both a structural ECM component and a local regulator of TGF-beta tissue deposition and signaling.\",\n      \"method\": \"Gene trap knockout mouse model, histology, immunohistochemistry, phospho-Smad2 immunoblot, ECM analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined cellular and molecular phenotypes, highly cited foundational paper\",\n      \"pmids\": [\"12208849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LTBP-4-deficient lung fibroblasts produce decreased active TGF-beta but increased secretion of latent TGF-beta, demonstrating LTBP-4 is required for TGF-beta activation (not secretion); loss of LTBP-4-mediated TGF-beta1 activation leads to enhanced BMP-4 signaling and decreased gremlin expression in the lung, a phenotype rescued by LTBP-4 transfection but not LTBP-1 transfection, and restored to wild-type by active TGF-beta1 treatment.\",\n      \"method\": \"Fibroblast cultures from LTBP-4-/- mice, TGF-beta bioassay, microarray, transfection rescue, cytokine treatment\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including KO cells, rescue experiments, and functional assays\",\n      \"pmids\": [\"15466481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LTBP-4 possesses heparin-binding activity particularly in its N-terminal region; LTBP-4 binds directly to fibronectin (FN) through N-terminal sites, and FN is indispensable for ECM assembly of LTBP-4. In FN-/- fibroblasts, LTBP-mediated ECM targeting was disturbed and TGF-beta activity was increased. LTBP-4 C-terminal domain supports fibroblast adhesion, and heparin reduces both FN binding and cell adhesion.\",\n      \"method\": \"Heparin-affinity assay, pulldown/binding assay, cell adhesion assay, FN-/- fibroblasts, ECM fractionation, TGF-beta activity assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple direct binding assays and functional validation in FN-null cells with multiple readouts\",\n      \"pmids\": [\"18585707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LTBP-4S null mice show defects in elastogenesis visible as early as E14.5 in alveolar walls, blood vessel media, and airway epithelium; the air-sac septation defect is associated with excessive TGF-beta2 signaling and is reversed by lowering TGF-beta2 levels, while normalization of TGF-beta signaling does not rescue elastogenesis, demonstrating two independent functions of LTBP-4: regulation of elastic fiber assembly and regulation of TGF-beta levels in lungs.\",\n      \"method\": \"Ltbp4S-/- mouse model, histology, TGF-beta2 neutralization, developmental stage analysis\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via TGF-beta2 neutralization dissecting two distinct LTBP-4 functions in the same model\",\n      \"pmids\": [\"19016471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recessive loss-of-function mutations in LTBP4 cause impaired synthesis and lack of deposition of LTBP4 into the ECM, resulting in increased TGF-beta activity in cultured fibroblasts and defective elastic fiber assembly in multiple human organ systems, demonstrating that LTBP4 couples TGF-beta signaling and ECM assembly.\",\n      \"method\": \"Human genetics (patient mutations), cell culture from patient fibroblasts, TGF-beta activity assay, ECM analysis, histology\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function with functional validation in patient fibroblasts across multiple methods\",\n      \"pmids\": [\"19836010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LTBP-4L and LTBP-4S isoforms are regulated by two independent promoters with tissue-specific expression (liver expresses mainly LTBP-4L, lung and small intestine mainly LTBP-4S). During secretion, LTBP-4L complexes with TGF-beta1 while most LTBP-4S is secreted free. LTBP-4S is incorporated into the ECM while full-length LTBP-4L is not readily detectable in ECM.\",\n      \"method\": \"Northern blot, immunoblotting, ECM fractionation, promoter analysis, cell culture\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing isoform-specific differences in processing, complex formation, and ECM targeting\",\n      \"pmids\": [\"20175115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IAAM haplotype fibroblasts exposed to TGF-beta display reduced phospho-SMAD signaling compared to VTTT haplotype fibroblasts, consistent with LTBP4's role as a regulator of TGF-beta; LTBP4 nonsynonymous coding variants (V194I, T787A, T820A, T1140M) influence age at loss of ambulation in DMD patients.\",\n      \"method\": \"Patient fibroblast TGF-beta stimulation assay, phospho-SMAD immunoblot, clinical cohort genotyping\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional fibroblast assay supporting genetic association, single method for mechanism\",\n      \"pmids\": [\"23440719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Inactivation of both LTBP-4 isoforms (Ltbp4-/-) in mice revealed that LTBP-4L is specifically required for incorporation of fibulin-4 into the ECM. Fibulin-4 was identified as a novel interaction partner of both LTBP-4 isoforms by co-immunoprecipitation. In Ltbp4S-/- mice (expressing only LTBP-4L), fibulin-4 ECM incorporation was normal, but was defective in Ltbp4-/- mice.\",\n      \"method\": \"Ltbp4-/- mouse model, co-immunoprecipitation, ECM fractionation, comparative analysis of isoform-specific knockout mice\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP identification of interaction partner plus functional validation in isoform-specific knockout models\",\n      \"pmids\": [\"25713297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Genetic epistasis in Ltbp4S-/-;Fibulin-4R/R compound mice showed severely impaired elastogenesis, defective alveolar septation, fragmented elastic lamellae, and aortic aneurysm formation not seen in single mutants alone, establishing a functional interaction between Ltbp-4L and fibulin-4 as a crucial requirement for survival and elastogenesis in vivo.\",\n      \"method\": \"Compound mutant mouse genetics, histology, survival analysis\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis with multiple defined phenotypic readouts confirming biochemical interaction\",\n      \"pmids\": [\"27585882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LTBP4 induces Pdgfrβ signaling by inhibiting the antioxidant Nrf2/Keap1 pathway in a TGF-beta-dependent manner; Ltbp4S-/- mice have defective Pdgfrβ signaling contributing to pulmonary emphysema.\",\n      \"method\": \"Ltbp4S-/- mouse model, gene expression analysis, pathway inhibition/activation experiments\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — pathway placement by KO with molecular readouts but limited direct mechanistic validation\",\n      \"pmids\": [\"27645114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Three interacting mechanisms contribute to alveolar septation defects in Ltbp4-/- lungs: absence of intact elastic fiber network, reduced angiogenesis, and upregulation of TGF-beta activity resulting in profibrotic processes.\",\n      \"method\": \"Ltbp4-/- mouse lung analysis, histology, angiogenesis assays, TGF-beta signaling readouts\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO model with multiple defined mechanistic readouts in a single study\",\n      \"pmids\": [\"28684544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pro-inflammatory Ly6Cpos macrophages in DMD muscle exhibit high LTBP4 expression, producing elevated latent-TGF-beta1; AMPK activation decreases ltbp4 expression in these macrophages, reducing latent-TGF-beta1 production and fibrosis. Fibro-adipogenic progenitors provide TGF-beta-activating enzymes that act on LTBP4-sequestered TGF-beta1 to produce collagen from fibroblasts, establishing an AMPK-LTBP4 axis controlling TGF-beta1 production and fibrosis in DMD.\",\n      \"method\": \"Mouse and human DMD muscle analysis, macrophage isolation, AMPK activation (AICAR treatment), ltbp4 knockdown, fibroblast collagen assays, in vivo pharmacological inhibition\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vitro and in vivo experiments with defined molecular mechanism and phenotypic readouts\",\n      \"pmids\": [\"30463013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Long-range regulatory variants at the LTBP4 locus (tagged by rs710160 on chr19) are associated with prolonged ambulation in DMD, with chromatin interaction data indicating these SNPs regulate LTBP4 expression; THBS1 (thrombospondin-1) was identified as an activator of TGF-beta signaling by direct binding to LTBP4.\",\n      \"method\": \"GWAS, gene expression databases, chromatin interaction analysis\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — GWAS/computational analysis; THBS1 direct binding to LTBP4 cited without direct experimental evidence in this paper\",\n      \"pmids\": [\"30014611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Fibulin-4 induces a conformational switch in LTBP-4L from a compact to an elongated structure; this conformational change is induced only by fibulin-4 multimers (not monomers) through increased avidity, and results in enhanced LTBP-4L binding to fibronectin and fibrillin-1, increased LTBP-4L assembly, and promotion of tropoelastin deposition onto elongated LTBP-4L. Fibulin-4 acts as a molecular extracellular chaperone for LTBP-4L.\",\n      \"method\": \"Biophysical conformational assays, binding assays (fibronectin, fibrillin-1, tropoelastin), recombinant protein reconstitution, fibulin-4 monomer vs multimer comparison\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with multiple binding assays, conformational analysis, mechanistic mutagenesis-equivalent (monomer vs multimer), single rigorous paper\",\n      \"pmids\": [\"31548410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LTBP4 deficiency (Ltbp4S-/- mice) leads to aggravated tubular interstitial fibrosis after unilateral ureteral obstruction; LTBP4 overexpression in proximal tubule cells stimulates angiogenesis via VEGFA upregulation and VEGFR activation in endothelial cells. LTBP4-deficient mice show aberrant angiogenesis, abnormal mitochondrial morphology, and enhanced oxidative stress.\",\n      \"method\": \"Ltbp4S-/- mouse UUO model, LTBP4 overexpression in HK-2 cells, transcriptomic analysis, tube formation assay, mitochondrial morphology analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple readouts in KO mouse and overexpression model, novel non-TGF-beta functions identified\",\n      \"pmids\": [\"34645813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Aberrant interaction between mutated ADAMTSL2 and LTBP4 upregulates TGF-beta signaling in human fibroblasts; variant pairs in ADAMTSL2-LTBP4 affect the protein-protein interaction between these two molecules.\",\n      \"method\": \"Exome sequencing, Co-IP/interaction assay in human fibroblasts, TGF-beta signaling readout\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single interaction/functional assay in patient-derived context demonstrating ADAMTSL2 as LTBP4 binding partner\",\n      \"pmids\": [\"34958866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"YAP overexpression in vascular smooth muscle cells promotes LTBP4 expression; silencing LTBP4 abolishes the protective role of YAP against abdominal aortic aneurysm formation, placing LTBP4 downstream of YAP in elastic fiber assembly in VSMCs.\",\n      \"method\": \"VSMC-specific YAP overexpression mouse model, LTBP4 silencing in vivo, AAA experimental model, histology\",\n      \"journal\": \"Journal of cardiovascular translational research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with defined phenotypic readout placing LTBP4 in YAP pathway\",\n      \"pmids\": [\"35708897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"LTBP4 knockdown in melanoma cells increases the percentage of active TGF-beta1 secreted; active TGF-beta1 inhibits YAP1 phosphorylation and induces YAP1 nuclear translocation, reducing Hippo signaling targets CTGF, Cyr61, and Birc5. LTBP4 overexpression activates the Hippo pathway via increased YAP1 phosphorylation and nuclear-cytoplasmic translocation, suppressing proliferation and metastasis.\",\n      \"method\": \"LTBP4 KD/OE in melanoma cells, ELISA for active TGF-beta1, immunofluorescence, Western blot, luciferase reporter, nude mouse tumor formation\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods linking LTBP4 to TGF-beta1 activation and Hippo-YAP1 pathway with functional readouts\",\n      \"pmids\": [\"35252214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LTBP4 deficiency in mice and HK-2 cells increases mitochondrial fragmentation (DRP1-dependent), decreases ATP production, reduces mitochondrial respiration and glycolysis, increases oxidative stress, and reduces angiogenesis after ischemia-reperfusion injury. Inhibition of DRP1-dependent mitochondrial fission ameliorated inflammation, oxidative stress, and fibrosis in LTBP4-deficient mice.\",\n      \"method\": \"Ltbp4 KD mice, IRI model, LTBP4 KD HK-2 cells, mitochondrial function assays (bioenergetics), DRP1 inhibitor treatment, angiogenesis assays with conditioned media\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic studies linking LTBP4 to DRP1-dependent mitochondrial dynamics with pharmacological rescue\",\n      \"pmids\": [\"37232163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"N-linked glycans of LTBP-4L (but not fibulin-4) are critical for fibulin-4-mediated conformational extension of LTBP-4L; fibulin-5 strongly interacts with and induces conformational extension of LTBP-4S, requiring N-linked glycans of fibulin-5, leading to enhanced fibronectin binding, increased LTBP-4S deposition, and doubled elastic fiber formation. Two distinct molecular axes were defined: LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5, with synergistic effects on elastogenesis.\",\n      \"method\": \"Glycoproteomic analysis, enzymatic glycan removal, biophysical binding assays, recombinant protein reconstitution, elastic fiber formation assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with glycoproteomic analysis, multiple orthogonal biophysical and functional assays\",\n      \"pmids\": [\"40608550\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LTBP4 is an extracellular matrix glycoprotein that sequesters latent TGF-beta in the ECM via its 3rd 8-cysteine domain and is essential for TGF-beta activation (not secretion); it directly binds fibronectin via its N-terminal region for ECM assembly, interacts with fibulin-4 (which acts as a molecular chaperone inducing a compact-to-extended conformational switch in LTBP-4L) and fibulin-5 (which similarly extends LTBP-4S) to facilitate tropoelastin deposition and elastic fiber formation, with two isoforms (LTBP-4L and LTBP-4S) regulated by independent promoters showing distinct TGF-beta binding, secretion, and ECM targeting properties; loss of LTBP-4 function results in impaired TGF-beta activation leading to enhanced BMP-4 signaling, defective elastogenesis, and—through an AMPK-regulated axis in macrophages—promotes fibrosis via excess latent TGF-beta1 production.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LTBP4 is an extracellular matrix glycoprotein that serves dual functions as a structural scaffold for elastic fiber assembly and as a critical regulator of TGF-beta bioavailability. It sequesters latent TGF-beta in the ECM via its 3rd 8-cysteine repeat domain and is required for TGF-beta activation rather than secretion; loss of LTBP4 paradoxically increases latent TGF-beta secretion while reducing active TGF-beta, leading to compensatory BMP-4 upregulation in the lung [PMID:15466481, PMID:9660815]. Two isoforms (LTBP-4L and LTBP-4S), driven by independent promoters with distinct tissue expression and TGF-beta binding properties, undergo conformational extension upon interaction with fibulin-4 (LTBP-4L) or fibulin-5 (LTBP-4S), an N-glycan-dependent process that enhances fibronectin binding and tropoelastin deposition for elastic fiber formation [PMID:31548410, PMID:40608550, PMID:20175115]. Recessive loss-of-function mutations in LTBP4 cause a human connective tissue disorder with defective elastic fiber assembly and increased TGF-beta activity across multiple organ systems [PMID:19836010].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing LTBP4 as a new member of the LTBP/fibrillin superfamily resolved its modular domain architecture (20 EG modules, 4 TB/8-Cys modules) and predicted it to be a TGF-beta-binding microfibrillar protein.\",\n      \"evidence\": \"cDNA sequencing and Northern blot showing high cardiac expression\",\n      \"pmids\": [\"9271198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct demonstration of TGF-beta binding at this stage\", \"Protein-level validation not performed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that LTBP-4 forms disulfide-linked complexes with TGF-beta LAP via its 3rd 8-Cys repeat and is deposited in the ECM established it as a bona fide TGF-beta-sequestering matrix protein.\",\n      \"evidence\": \"cDNA cloning, immunoblotting, ECM fractionation, and plasmin release assay in human lung fibroblasts\",\n      \"pmids\": [\"9660815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LTBP-4 is required for TGF-beta activation versus secretion was unknown\", \"In vivo relevance not yet tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of a splice variant lacking the 3rd 8-Cys repeat revealed a mechanism for uncoupling LTBP4's structural ECM role from TGF-beta sequestration.\",\n      \"evidence\": \"RT-PCR and expression analysis across cell lines and tissues\",\n      \"pmids\": [\"11683420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of this variant in vivo was not tested\", \"Relative abundance across tissues not quantified at protein level\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Knockout of LTBP-4 in mice produced emphysema, cardiomyopathy, and colorectal cancer with reduced ECM TGF-beta deposition and phospho-Smad2, establishing LTBP4 as essential for both elastic fiber integrity and local TGF-beta signaling in vivo.\",\n      \"evidence\": \"Gene trap knockout mouse with histology, immunohistochemistry, and phospho-Smad2 immunoblot\",\n      \"pmids\": [\"12208849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of TGF-beta activation versus secretion not dissected\", \"Contribution of individual isoforms unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Using LTBP-4-null fibroblasts resolved that LTBP4 is required for TGF-beta activation (not secretion), and showed that loss of this activation leads to compensatory BMP-4 upregulation — a phenotype rescued by LTBP-4 but not LTBP-1 transfection.\",\n      \"evidence\": \"TGF-beta bioassay, microarray, and rescue experiments in Ltbp4−/− fibroblasts\",\n      \"pmids\": [\"15466481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which LTBP4 promotes TGF-beta activation not defined\", \"Whether LTBP-4L or LTBP-4S mediates this effect was not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping LTBP-4's N-terminal fibronectin-binding and heparin-binding sites, and showing that fibronectin is indispensable for LTBP-4 ECM assembly, established the upstream requirement for fibronectin in LTBP4-mediated TGF-beta regulation.\",\n      \"evidence\": \"Binding assays, cell adhesion assays, and ECM fractionation in FN−/− fibroblasts\",\n      \"pmids\": [\"18585707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the FN–LTBP4 interaction not resolved\", \"Whether fibronectin binding differs between LTBP-4L and LTBP-4S not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Isoform-specific (Ltbp4S−/−) knockout and TGF-beta2 neutralization dissected two independent functions of LTBP4 — elastic fiber assembly and TGF-beta regulation — since normalizing TGF-beta signaling rescued septation but not elastogenesis.\",\n      \"evidence\": \"Ltbp4S−/− mice with TGF-beta2 neutralization and developmental histology\",\n      \"pmids\": [\"19016471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of the elastogenesis-specific function not identified\", \"Whether LTBP-4L compensates partially in LTBP-4S-null lung unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Human recessive LTBP4 mutations causing impaired LTBP4 ECM deposition, increased TGF-beta activity, and defective elastic fibers in multiple organs established LTBP4 as a Mendelian connective tissue disease gene.\",\n      \"evidence\": \"Patient genetics with functional validation in patient fibroblasts and tissue histology\",\n      \"pmids\": [\"19836010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype–phenotype correlation across different mutations not fully mapped\", \"Whether residual LTBP-4 function modifies severity unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Characterizing two independent promoters driving LTBP-4L and LTBP-4S with distinct tissue expression, TGF-beta1 complex formation, and ECM incorporation properties explained why different tissues are differentially affected by LTBP4 loss.\",\n      \"evidence\": \"Northern blot, immunoblotting, ECM fractionation, and promoter analysis\",\n      \"pmids\": [\"20175115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional regulators of each promoter not identified\", \"Post-translational regulation of isoform-specific functions not explored\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of fibulin-4 as a direct LTBP-4 binding partner, with LTBP-4L specifically required for fibulin-4 ECM incorporation, linked the two proteins in a shared elastogenic pathway.\",\n      \"evidence\": \"Co-immunoprecipitation and comparative ECM analysis in Ltbp4S−/− versus Ltbp4−/− mice\",\n      \"pmids\": [\"25713297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding domain on LTBP-4 not mapped\", \"Whether fibulin-4 reciprocally affects LTBP-4 conformation was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Compound Ltbp4S−/−;Fibulin-4R/R mutant mice displayed synergistic lethality and elastogenic defects not seen in either single mutant, confirming functional interdependence of LTBP-4 and fibulin-4 in vivo.\",\n      \"evidence\": \"Compound mutant mouse genetics with survival analysis and histology\",\n      \"pmids\": [\"27585882\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether therapeutic supplementation of either protein can rescue the compound phenotype not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that pro-inflammatory macrophages produce LTBP4-bound latent TGF-beta1 under AMPK regulation, which is then activated by fibro-adipogenic progenitor-derived enzymes to drive collagen deposition, placed LTBP4 at the center of an inflammatory–fibrotic axis in DMD muscle.\",\n      \"evidence\": \"Macrophage isolation from DMD muscle, AMPK activation with AICAR, ltbp4 knockdown, fibroblast collagen assays, and in vivo pharmacology\",\n      \"pmids\": [\"30463013\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the FAP-derived TGF-beta-activating enzymes acting on LTBP4-sequestered complexes not determined\", \"Whether this axis operates in non-muscular fibrotic diseases unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Reconstitution experiments revealed that fibulin-4 multimers (not monomers) act as an extracellular chaperone switching LTBP-4L from a compact to an elongated conformation, thereby enhancing its binding to fibronectin and fibrillin-1 and promoting tropoelastin deposition.\",\n      \"evidence\": \"Recombinant protein reconstitution with biophysical conformational assays, binding assays, and monomer versus multimer comparison\",\n      \"pmids\": [\"31548410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural details of the compact versus extended states not resolved at atomic level\", \"Whether the conformational switch is reversible in vivo not known\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placing LTBP4 downstream of YAP in vascular smooth muscle cells, and showing that LTBP4 silencing abolishes YAP's protective effect against aortic aneurysm, identified a transcriptional regulatory input into LTBP4 expression relevant to vascular disease.\",\n      \"evidence\": \"VSMC-specific YAP overexpression mouse model with LTBP4 silencing and AAA phenotyping\",\n      \"pmids\": [\"35708897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional regulation of the LTBP4 promoter by YAP not demonstrated\", \"Reciprocal LTBP4-to-YAP signaling via TGF-beta creates potential confounding\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linking LTBP4 deficiency to DRP1-dependent mitochondrial fragmentation, reduced bioenergetics, and increased oxidative stress — phenotypes rescued by DRP1 inhibition — revealed an unexpected intracellular consequence of LTBP4 loss beyond canonical ECM functions.\",\n      \"evidence\": \"LTBP4 knockdown in HK-2 cells and mice with IRI, mitochondrial bioenergetic profiling, and DRP1 inhibitor rescue\",\n      \"pmids\": [\"37232163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the mitochondrial phenotype is a direct effect or secondary to altered TGF-beta signaling not resolved\", \"Mechanism linking an ECM protein to DRP1 regulation not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that N-linked glycans on LTBP-4L are required for fibulin-4-induced extension, while fibulin-5 glycans drive LTBP-4S extension, defined two parallel glycan-dependent molecular axes (LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5) that synergistically promote elastogenesis.\",\n      \"evidence\": \"Glycoproteomic analysis, enzymatic glycan removal, biophysical binding assays, recombinant reconstitution, and elastic fiber formation assay\",\n      \"pmids\": [\"40608550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific glycan sites critical for each interaction not mapped\", \"In vivo validation of the dual-axis model not yet performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which LTBP4 promotes TGF-beta activation (as opposed to mere sequestration) remains undefined, as does the structural basis for the compact-to-extended conformational transition at atomic resolution.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No reconstituted TGF-beta activation assay using purified LTBP4\", \"Atomic-resolution structure of LTBP-4 in compact versus extended states unavailable\", \"How the two isoform-specific elastogenic axes are coordinated in vivo during development is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 6, 14]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [3, 6, 11, 16, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 3, 5, 7, 8, 10, 16, 22]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 5, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 4, 6, 7, 9, 14, 20]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [3, 5, 6, 10, 11, 16, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 11, 22]}\n    ],\n    \"complexes\": [\n      \"Latent TGF-beta complex (large latent complex)\"\n    ],\n    \"partners\": [\n      \"TGFB1\",\n      \"FN1\",\n      \"FBLN4\",\n      \"FBLN5\",\n      \"FBN1\",\n      \"ELN\",\n      \"ADAMTSL2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}